| HOME >> BIOLOGY >> TECHNOLOGY |
-- Acquisition Extends the Company's Suite of Products and Increases Breadth of EDC Customers --
FORT LAUDERDALE, Fla. and PHILADELPHIA, June 23 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. (R) (OTC Bulletin Board: OMCM) ("OmniComm") a leader in integrated electronic data capture (EDC) solutions for clinical trials, and eResearchTechnology, Inc. (Nasdaq: ERES) ("ERT"), a global provider of technology and services that enable the pharmaceutical, biotechnology, and medical device industries worldwide to collect, interpret, and distribute cardiac safety and clinical data, today announced that OmniComm has acquired the EDC business of ERT.
"We believe strongly in the long-term growth of the EDC and eClinical markets. We have positioned ourselves to be a leading provider of EDC solutions and expect this transaction to allow us to grow more rapidly. By combining the two EDC businesses, OmniComm extends and deepens its roster of EDC customers and gains several key technologies that can be added to the TrialMaster(R) eClinical suite of applications," stated Cornelis F. Wit, CEO of OmniComm Systems. "We believe that we will be able to leverage our existing EDC infrastructure and expertise to further penetrate the combined portfolio of customers."
Mr. Wit continued, "the eClinical industry is going through a period of consolidation and we believe that only those firms that can combine superior products and services along with a demonstrated ability to deliver a broad array of solutions will be able to effectively compete. We are dedicated to broadening the products and services we offer and developing as diverse a client base as possible. Our expansion into Europe during 2007-2008 was the first prong of executing on this strategy. ERT has served several markets, including the governmental sector and Fortune 500
'/>"/>
| SOURCE OmniComm Systems, Inc. Copyright©2009 PR Newswire. All rights reserved |